FDA Gives Go-ahead for Phase 1/2 Trial Testing VY-HTT01 Gene Therapy

Retrieved on: 2021-04-27 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

FDA Gives Go-ahead for Phase 1/2 Trial Testing VY-HTT01 Gene Therapy. View article details on hiswai:

Excerpt

When cells “read” the HTT gene to make the HTT protein, a molecule called messenger RNA, or mRNA, is made in an intermediate step between ...

Article found on: huntingtonsdiseasenews.com